FR2378035B1 - - Google Patents
Info
- Publication number
- FR2378035B1 FR2378035B1 FR7800673A FR7800673A FR2378035B1 FR 2378035 B1 FR2378035 B1 FR 2378035B1 FR 7800673 A FR7800673 A FR 7800673A FR 7800673 A FR7800673 A FR 7800673A FR 2378035 B1 FR2378035 B1 FR 2378035B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2031/77A GB1572912A (en) | 1977-01-19 | 1977-01-19 | Clavulanic acid esters |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2378035A1 FR2378035A1 (fr) | 1978-08-18 |
FR2378035B1 true FR2378035B1 (uk) | 1982-11-19 |
Family
ID=9732402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7800673A Granted FR2378035A1 (fr) | 1977-01-19 | 1978-01-11 | Esters de l'acide clavulanique |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS5390289A (uk) |
BE (1) | BE862764A (uk) |
DE (1) | DE2802049A1 (uk) |
FR (1) | FR2378035A1 (uk) |
GB (1) | GB1572912A (uk) |
NL (1) | NL7800604A (uk) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3063683D1 (en) * | 1979-08-24 | 1983-07-14 | Beecham Group Plc | Amine salt of clavulanic acid, its preparation and use |
EP0042220B1 (en) * | 1980-06-11 | 1984-08-15 | Beecham Group Plc | Process for the preparation of beta-lactam antibiotics |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2635477A1 (de) * | 1975-08-20 | 1977-03-03 | Beecham Group Ltd | Verfahren zur herstellung fester, praktisch reiner natrium- und kaliumsalze der clavulansaeure |
-
1977
- 1977-01-19 GB GB2031/77A patent/GB1572912A/en not_active Expired
-
1978
- 1978-01-09 BE BE184209A patent/BE862764A/xx not_active IP Right Cessation
- 1978-01-11 FR FR7800673A patent/FR2378035A1/fr active Granted
- 1978-01-14 JP JP323178A patent/JPS5390289A/ja active Pending
- 1978-01-18 NL NL7800604A patent/NL7800604A/xx not_active Application Discontinuation
- 1978-01-18 DE DE19782802049 patent/DE2802049A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NL7800604A (nl) | 1978-07-21 |
GB1572912A (en) | 1980-08-06 |
JPS5390289A (en) | 1978-08-08 |
DE2802049A1 (de) | 1978-07-20 |
FR2378035A1 (fr) | 1978-08-18 |
BE862764A (fr) | 1978-07-10 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |